The Danish pharmaceutical giant Novo Nordisk initiated a revolution in weight management with its groundbreaking therapies Ozempic and Wegovy. However, the company now faces a period of substantial upheaval following
The Danish pharmaceutical giant Novo Nordisk initiated a revolution in weight management with its groundbreaking therapies Ozempic and Wegovy. However, the company now faces a period of substantial upheaval following
The £1.7 billion takeover scramble for Assura, Britain’s prominent primary healthcare property firm, has taken a heated turn. Major UK shareholders have openly rejected an acquisition attempt led by US
In a devastating blow to investor confidence, Moderna’s shares experienced a dramatic decline of up to 22 per cent on Monday following disappointing sales forecasts from the US biotech giant.
The struggling consumer healthcare company Alliance Pharma appears poised to exit London’s junior stock exchange following a £350 million takeover bid from activist investor Dbay Advisors. The Isle of Man-based






